Key result
MSA and IOH show lower CSF MHPG than controls, while only IOH has low plasma MHPG.
Why the study?
The mechanisms underlying low CSF and plasma MHPG levels in patients with orthostatic hypotension due to MSA or IOH were unclear.
Do CSF and plasma levels of MHPG differ between patients with orthostatic hypotension (MSA or IOH) and normal controls?
Population
Patients with orthostatic hypotension due to MSA or IOH
Comparison
Patients with MSA or IOH vs normal controls
Design
Observational cross-sectional study
Authors
Loading...
May distinguish central noradrenergic dysfunction in MSA; hypothesis-generating and should not yet change practice.
Observational
Do CSF and plasma levels of MHPG differ between patients with orthostatic hypotension (MSA or IOH) and normal controls?
CSF and plasma MHPG levels can help differentiate the underlying pathophysiology of central versus peripheral noradrenergic dysfunction in patients with orthostatic hypotension.
Polinsky et al. (1984) conducted an observational in Orthostatic hypotension. Multiple system atrophy (MSA) or idiopathic orthostatic hypotension (IOH) vs. Normal controls was evaluated on CSF and plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG). Patients with multiple system atrophy or idiopathic orthostatic hypotension had significantly lower total CSF MHPG levels than normal controls, with only IOH patients having low plasma MHPG levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: